|
EP3787634A1
|
|
Inositol-based immunotherapies
|
|
EP2968617A1
|
|
Myo-inositol trispyrophosphate as an anti-obesity agent
|
|
US2014179635A1
|
|
Tumor eradication by inositol-tripyrophosphate
|
|
US2014142052A1
|
|
Phosphorylated polyols, pyrophosphates, and derivatives thereof having biological activity
|
|
WO2012045009A2
|
|
Polyphosphate and pyrophosphate derivative of saccharides
|
|
CN102573853A
|
|
Method of reducing multi-drug resistance using inositol tripyrophosphate
|
|
US2009029951A1
|
|
Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
|
|
CA2725788A1
|
|
Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
|
|
CA2674048A1
|
|
Cyclitols and their derivatives and their therapeutic applications
|
|
EP1973398A1
|
|
Use of inositol-tripyrophosphate in treating tumors mediated by angiogenesis
|
